AXSM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 22.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $6,404,138.49

Axsome Therapeutics Insider Trading History Chart

Axsome Therapeutics Share Price & Price History

^$109.92

▲ +2.68 (2.50%)

As of 04/29/2025 05:00 PM ET

Days: 30 | 90 | 365

Axsome Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/14/2025	Nick Pizzie	CFO	Sell	3,000	$131.07	$393,210.00	42,187
9/11/2024	Mark E. Saad	Director	Sell	11,016	$91.31	$1,005,870.96	10,002
8/9/2024	Mark L. Jacobson	COO	Sell	47,739	$84.26	$4,022,488.14	5,783
5/29/2024	Mark L. Jacobson	COO	Sell	7,910	$74.31	$587,792.10	5,783
5/28/2024	Mark Coleman	Director	Sell	5,249	$75.21	$394,777.29	19,848
4/1/2024	Mark L. Jacobson	COO	Sell	24,662	$77.24	$1,904,892.88
3/14/2024	Roger Jeffs	Director	Sell	29,976	$69.70	$2,089,327.20	120,756
9/15/2023	Mark Coleman	Director	Sell	11,016	$75.19	$828,293.04	25,097

SEC Filings (Institutional Ownership Changes) for Axsome Therapeutics (NASDAQ:AXSM)

81.49% of Axsome Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Axsome Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/29/2025	Envestnet Asset Management Inc.	25,043	$2.92M	0.0%	-28.7%	0.051%
4/29/2025	Penserra Capital Management LLC	19,112	$2.23M	0.0%	N/A	0.039%
4/29/2025	Bank of New York Mellon Corp	131,023	$15.28M	0.0%	-2.6%	0.269%
4/29/2025	GF Fund Management CO. LTD.	1,241	$0.15M	0.0%	+21.9%	0.003%
4/29/2025	OneDigital Investment Advisors LLC	8,240	$0.96M	0.0%	-3.4%	0.017%
4/29/2025	Moody Aldrich Partners LLC	62,339	$7.27M	1.5%	+38.1%	0.128%
4/28/2025	D.A. Davidson & CO.	6,755	$0.79M	0.0%	-17.9%	0.014%
4/28/2025	Principal Financial Group Inc.	295,671	$34.48M	0.0%	+42.8%	0.606%
4/28/2025	Teacher Retirement System of Texas	8,475	$0.99M	0.0%	-8.3%	0.017%
4/28/2025	DAVENPORT & Co LLC	1,867	$0.22M	0.0%	N/A	0.004%
4/25/2025	Peregrine Capital Management LLC	59,721	$6.97M	0.2%	-31.5%	0.122%
4/25/2025	Lisanti Capital Growth LLC	33,280	$3.88M	1.2%	N/A	0.068%
4/24/2025	Trust Co. of Vermont	400	$47K	0.0%	-20.0%	0.001%
4/18/2025	Prosperity Wealth Management Inc.	2,750	$0.32M	0.2%	N/A	0.006%
4/17/2025	Janney Montgomery Scott LLC	14,923	$1.74M	0.0%	+8.6%	0.031%
4/16/2025	Wealth Enhancement Advisory Services LLC	20,644	$2.41M	0.0%	+5.2%	0.042%
4/15/2025	Assenagon Asset Management S.A.	627,418	$73.18M	0.1%	+16,852.7%	1.287%
4/15/2025	SG Americas Securities LLC	2,751	$0.32M	0.0%	-22.6%	0.006%
4/14/2025	Pallas Capital Advisors LLC	35,280	$4.12M	0.2%	+33.5%	0.072%
4/10/2025	Hennion & Walsh Asset Management Inc.	59,273	$6.91M	0.3%	+2.5%	0.122%
4/9/2025	NBC Securities Inc.	273	$31K	0.0%	N/A	0.001%
4/8/2025	Rhumbline Advisers	54,760	$6.39M	0.0%	+6.9%	0.112%
4/7/2025	GAMMA Investing LLC	22,043	$2.57M	0.0%	+38,571.9%	0.045%
3/24/2025	Wellington Management Group LLP	673,157	$56.96M	0.0%	-9.4%	1.380%
3/18/2025	111 Capital	3,291	$0.28M	0.1%	N/A	0.007%
3/17/2025	Wealth Enhancement Advisory Services LLC	19,627	$1.66M	0.0%	-0.9%	0.040%
3/5/2025	Phocas Financial Corp.	17,546	$1.49M	0.2%	-0.9%	0.036%
2/21/2025	TFG Asset Management GP Ltd	41,250	$3.49M	0.7%	N/A	0.085%
2/19/2025	GF Fund Management CO. LTD.	1,018	$86K	0.0%	N/A	0.002%
2/18/2025	Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.	33,719	$2.85M	0.3%	N/A	0.070%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	57,642	$4.88M	0.0%	+20.8%	0.119%
2/17/2025	Woodline Partners LP	408,441	$34.56M	0.2%	+36.8%	0.843%
2/17/2025	Two Sigma Advisers LP	6,300	$0.53M	0.0%	+85.3%	0.013%
2/17/2025	TFG Asset Management GP Ltd	41,250	$3.49M	0.9%	N/A	0.085%
2/17/2025	Sherbrooke Park Advisers LLC	4,082	$0.35M	0.1%	+21.9%	0.008%
2/17/2025	RTW Investments LP	4,051,365	$342.79M	5.2%	-3.3%	8.360%
2/17/2025	Rafferty Asset Management LLC	3,630	$0.31M	0.0%	-22.5%	0.007%
2/17/2025	Raiffeisen Bank International AG	600	$51K	0.0%	N/A	0.001%
2/17/2025	Point72 Europe London LLP	41,734	$3.53M	0.2%	+20.7%	0.086%
2/17/2025	ProShare Advisors LLC	12,664	$1.07M	0.0%	+30.3%	0.026%
2/17/2025	MPM Bioimpact LLC	50,000	$4.23M	0.6%	N/A	0.103%
2/17/2025	Man Group plc	163,388	$13.82M	0.0%	N/A	0.337%
2/17/2025	Nuveen Asset Management LLC	221,202	$18.72M	0.0%	+118.1%	0.456%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	20,921	$1.77M	0.0%	+4.9%	0.043%
2/17/2025	Lazard Asset Management LLC	537,669	$45.49M	0.1%	+525.7%	1.110%
2/17/2025	Frontier Capital Management Co. LLC	52,768	$4.47M	0.0%	-56.2%	0.109%
2/17/2025	Fairmount Funds Management LLC	1,468,983	$124.29M	12.4%	-37.8%	3.031%
2/17/2025	Deutsche Bank AG	120,547	$10.20M	0.0%	+37.4%	0.249%
2/17/2025	Cubist Systematic Strategies LLC	116,937	$9.89M	0.1%	N/A	0.241%
2/17/2025	Cetera Investment Advisers	7,109	$0.60M	0.0%	+19.5%	0.015%
2/17/2025	Brevan Howard Capital Management LP	38,748	$3.28M	0.0%	+169.9%	0.080%
2/17/2025	Bridgefront Capital LLC	10,555	$0.89M	0.3%	N/A	0.022%
2/17/2025	Captrust Financial Advisors	2,953	$0.25M	0.0%	-48.4%	0.006%
2/17/2025	Avidity Partners Management LP	188,000	$15.91M	1.6%	-36.5%	0.388%
2/17/2025	BVF Inc. IL	1,388,064	$117.44M	4.0%	+32.7%	2.864%
2/17/2025	Balyasny Asset Management L.P.	181,213	$15.33M	0.0%	+171.0%	0.374%
2/17/2025	Bellevue Group AG	118,930	$10.06M	0.2%	-67.6%	0.245%
2/17/2025	BNP Paribas Financial Markets	185,661	$15.71M	0.0%	+1,251.9%	0.383%
2/17/2025	Ameriprise Financial Inc.	18,238	$1.54M	0.0%	-90.8%	0.038%
2/17/2025	Alethea Capital Management LLC	734,317	$62.13M	53.2%	-0.6%	1.515%
2/17/2025	Ally Bridge Group NY LLC	66,661	$5.64M	4.7%	N/A	0.138%
2/14/2025	Boxer Capital Management LLC	470,000	$39.77M	3.4%	N/A	0.970%
2/14/2025	Comerica Bank	7,374	$0.62M	0.0%	-32.6%	0.015%
2/14/2025	PDT Partners LLC	4,195	$0.36M	0.0%	-64.1%	0.009%
2/14/2025	Schonfeld Strategic Advisors LLC	25,380	$2.15M	0.0%	-69.0%	0.052%
2/14/2025	Northern Trust Corp	402,500	$34.06M	0.0%	+21.0%	0.831%
2/14/2025	The Manufacturers Life Insurance Company	22,317	$1.89M	0.0%	-1.4%	0.046%
2/14/2025	Quarry LP	750	$63K	0.0%	-62.5%	0.002%
2/14/2025	Tri Locum Partners LP	249,769	$21.13M	4.4%	+172.3%	0.515%
2/14/2025	Aquatic Capital Management LLC	903	$76K	0.0%	N/A	0.002%
2/14/2025	Virtus ETF Advisers LLC	3,705	$0.31M	0.1%	-18.4%	0.008%
2/14/2025	Seven Springs Wealth Group LLC	4,005	$0.34M	0.1%	N/A	0.008%
2/14/2025	Voya Investment Management LLC	102,742	$8.69M	0.0%	+8.7%	0.212%
2/14/2025	Adage Capital Partners GP L.L.C.	60,000	$5.08M	0.0%	-88.6%	0.124%
2/14/2025	Hood River Capital Management LLC	644,785	$54.56M	0.8%	+3.2%	1.331%
2/14/2025	Price T Rowe Associates Inc. MD	31,228	$2.64M	0.0%	+12.1%	0.064%
2/14/2025	Hsbc Holdings PLC	136,785	$11.57M	0.0%	-0.2%	0.282%
2/14/2025	OneDigital Investment Advisors LLC	8,528	$0.72M	0.0%	-2.4%	0.018%
2/14/2025	Tower Research Capital LLC TRC	4,573	$0.39M	0.0%	+612.3%	0.009%
2/14/2025	Teachers Retirement System of The State of Kentucky	9,276	$0.79M	0.0%	-18.3%	0.019%
2/14/2025	MetLife Investment Management LLC	22,277	$1.89M	0.0%	+5.9%	0.046%
2/14/2025	Natixis	748	$63K	0.0%	-16.0%	0.002%
2/14/2025	First Trust Advisors LP	54,580	$4.62M	0.0%	+26.7%	0.113%
2/14/2025	1492 Capital Management LLC	11,385	$0.96M	0.5%	N/A	0.023%
2/13/2025	CANADA LIFE ASSURANCE Co	3,112	$0.26M	0.0%	-7.1%	0.006%
2/13/2025	Canada Pension Plan Investment Board	4,100	$0.35M	0.0%	N/A	0.008%
2/13/2025	Marshall Wace LLP	127,097	$10.75M	0.0%	N/A	0.262%
2/13/2025	Affinity Asset Advisors LLC	75,000	$6.35M	0.8%	-6.3%	0.155%
2/13/2025	Guggenheim Capital LLC	11,606	$0.98M	0.0%	-13.2%	0.024%
2/13/2025	XTX Topco Ltd	13,151	$1.11M	0.1%	N/A	0.027%
2/13/2025	Mariner LLC	15,120	$1.28M	0.0%	+13.8%	0.031%
2/13/2025	Barclays PLC	97,988	$8.29M	0.0%	+58.6%	0.202%
2/13/2025	Summit Investment Advisors Inc.	3,852	$0.33M	0.3%	+4.4%	0.008%
2/13/2025	Synovus Financial Corp	16,128	$1.37M	0.0%	+1.8%	0.033%
2/13/2025	Granite Investment Partners LLC	91,649	$7.75M	0.3%	N/A	0.189%
2/13/2025	Kennedy Capital Management LLC	37,941	$3.21M	0.1%	+95.3%	0.078%
2/13/2025	Raymond James Financial Inc.	174,586	$14.77M	0.0%	N/A	0.360%
2/13/2025	Legal & General Group Plc	36,370	$3.08M	0.0%	-1.4%	0.075%
2/13/2025	Invesco Ltd.	692,464	$58.59M	0.0%	+10.8%	1.429%
2/13/2025	ADAR1 Capital Management LLC	19,661	$1.66M	0.3%	+3,176.8%	0.041%

Data available starting January 2016

See Full Table

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist with multimodal activity indicated for the treatment of major depressive disorder; and Sunosi (solriamfetol), a medication indicated to the treatment of excessive daytime sleepiness in patients with narcolepsy or obstructive sleep apnea. It is also developing AXS-05, which is in Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation; AXS-07, an investigational medicine that has completed Phase III trials for the acute treatment of migraine; AXS-12, an investigational medicine, which is in Phase III trial to treat narcolepsy; AXS-14, a selective and potent norepinephrine reuptake inhibitor that has completed Phase III trial for the treatment of fibromyalgia and other conditions; and solriamfetol, a dual-acting dopamine and norepinephrine reuptake inhibitor, which has completed a Phase 2 trial for treating attention-deficit/hyperactivity disorder, and is in phase 2 major depressive, binge eating, and shift work disorder. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.

Today's Range

Now: $109.92

$107.22

$111.42

50 Day Range

MA: $114.76

$95.65

$137.75

52 Week Range

Now: $109.92

$64.11

$139.13

Volume

606,079 shs

Average Volume

683,533 shs

Market Capitalization

$5.36 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.88

Who are the company insiders with the largest holdings of Axsome Therapeutics?: Axsome Therapeutics' top insider investors include:
Roger Jeffs (Director)
Nick Pizzie (CFO)
Mark Coleman (Director)
Mark E Saad (Director)
Mark L Jacobson (COO)
Mark L Jacobson (COO)
Learn More about top insider investors at Axsome Therapeutics.
Who are the major institutional investors of Axsome Therapeutics?: Axsome Therapeutics' top institutional shareholders include:
Assenagon Asset Management S.A. — 1.29%
Principal Financial Group Inc. — 0.61%
Bank of New York Mellon Corp — 0.27%
Moody Aldrich Partners LLC — 0.13%
Peregrine Capital Management LLC — 0.12%
Hennion & Walsh Asset Management Inc. — 0.12%
Learn More about top institutional investors of Axsome Therapeutics stock.
Which institutional investors are selling Axsome Therapeutics stock?: During the last quarter, AXSM stock was sold by these institutional investors:
Peregrine Capital Management LLC
Envestnet Asset Management Inc.
Bank of New York Mellon Corp
D.A. Davidson & CO.
SG Americas Securities LLC
Teacher Retirement System of Texas
OneDigital Investment Advisors LLC
Trust Co. of Vermont
During the last year, company insiders that have sold Axsome Therapeutics company stock include:
Roger Jeffs (Director)
Nick Pizzie (CFO)
Mark Coleman (Director)
Mark E Saad (Director)
Learn More investors selling Axsome Therapeutics stock.
Which institutional investors are buying Axsome Therapeutics stock?: Within the previous quarter, AXSM stock was bought by institutional investors including:
Assenagon Asset Management S.A.
Principal Financial Group Inc.
Lisanti Capital Growth LLC
GAMMA Investing LLC
Penserra Capital Management LLC
Moody Aldrich Partners LLC
Pallas Capital Advisors LLC
Rhumbline Advisers